Panbela Therapeutics Inc. Gains 46.39%
Thu, Sep 22, 2022 at 07:26 PM
Panbela Therapeutics Inc. (PBLA:NASDAQ) shot up at $0.36, representing a gain of 46.4%. On Thu, Sep 22, 2022, PBLA:NASDAQ touched a New 2-Week Intraday Low of $0.21. From Thu, Sep 08, 2022, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Fri, Sep 16, 2022 at $1 with a volume of 15M+.
About Panbela Therapeutics Inc. (PBLA:NASDAQ)
Panbela Therapeutics Inc is a clinical-stage drug development company.
Top 10 Gainers:
- Spero Therapeutics, Inc. (SPRO:NASDAQ), 167.74%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 105.9%
- Panbela Therapeutics Inc. (PBLA:NASDAQ), 46.39%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 44.69%
- ShiftPixy, Inc. (PIXY:NASDAQ), 38.95%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 35.65%
- Cano Health Inc. Class A (CANO:NYSE), 32.17%
- iSpecimen Inc. (ISPC:NASDAQ), 26.49%
- Heliogen Inc. (HLGN:NYSE), 23.56%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 23.48%